medigraphic.com
SPANISH

Dermatología Cosmética, Médica y Quirúrgica

Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2018; 16 (4)

RAVEN: Exceptional Case of Epidermal Nevus with Characteristics of Acanthosis Nigricans

Diez MJC, Cabrera H, Antezana C, Sangueza M
Full text How to cite this article

Language: Spanish
References: 14
Page: 286-289
PDF size: 241.23 Kb.


Key words:

RAVEN, acanthosis nigricans, hamartoma.

ABSTRACT

Epidermal nevi (NE) are low frequency cutaneous hamartomas originated in pluripotential cells from embryonic ectoderm. This cutaneous disembryoplasias can be congenital or appear during the first years of life. Different variants are recognized according to their morphology, histopathology and topography. The acronym raven (rounded and velvety epidermal nevus) refers to an epidermal hamartoma whose histopathology is similar to acanthosis nigricans. We present the first case in a 14-year-old male from Bolivia and we highlight its main characteristics.


REFERENCES

  1. Cabrera HN y García SM, Nevos epidérmicos, Buenos Aires, Actualizaciones Médicas, 1998.

  2. Hafner C, Van Oers JM, Vogt T, Landthaler M et al., Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi, J Clin Invest 2006; 116:2201-7.

  3. Hafner C, Toll A, Gantner S, Mauerer A et al., Keratinocytic epidermal nevi are associated with mosaic ras mutations, J Med Genet 2012; 49:249-53.

  4. Meyers GA, Orlow SJ, Munro IR, Przylepa KA y Jabs EW, Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans, Nat Genet 1995; 11:462-4.

  5. Muenke M et al., A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome, Am J Hum Genet 1997; 60:555-64.

  6. Vajo Z, Francomano CA y Wilkin DJ, The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acantosis nigricans, Endocr Rev 2000; 21:23-39.

  7. Baker KM, Olson DS, Harding CO y Pauli RM, Long-term survival in typical thanatophoric dysplasia type 1, Am J Med Genet 1997; 70: 427-36.

  8. Webster MK y Donoghue DJ, FGFR activation in skeletal disorders: too much of a good thing, Trends Genet 1997; 13:178-82.

  9. Castro Pérez G, Della Giovanna P, Cabrera HN y García S, Nevos epidérmicos: estudio retrospectivo de 133 casos, Dermatol Argent 2011; 17:46-9.

  10. Petit A, Lemarchand-Venencie F, Pinquier L, Lebbe C et al., Acanthosis nigricans nevoide ou RAVEN (rounded and velvety epidermal nevus): three cases, Ann Dermatol Venereol 2012; 139:183-8.

  11. Altman J y Mehregan AH, Inflammatory linear verrucose epidermal nevus, Arch Dermatol 1971; 104:385-9.

  12. Cabrera H y Hermida MD, RAVEN, forma particular de nevo epidérmico, Dermatol Argent 2014; 20(4):268-70.

  13. Choi BH y Kudo M, Abnormal neuronal migration and gliomatosis cerebri in epidermal nevus syndrome, Acta Neuropathol 1981; 53:319-25.

  14. De Waal AC, Van Rossum MM y Bovenschen HJ, Extensive segmental acanthosis nigricans form of epidermal nevus, Dermatol Online J 2010; 16:7.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Dermatología Cosmética, Médica y Quirúrgica. 2018;16